The largest database of trusted experimental protocols

Eosinophil purification kit

Manufactured by Miltenyi Biotec
Sourced in Germany

The Eosinophil Purification Kit is a laboratory equipment designed to isolate eosinophils from biological samples. It utilizes a proprietary method to selectively enrich eosinophils while maintaining their viability and functionality.

Automatically generated - may contain errors

3 protocols using eosinophil purification kit

1

Eosinophil Transwell Migration Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
Granulocyte layers were isolated from peripheral blood after density gradient centrifugation (Ficoll-Paque PLUS, GE Healthcare, Uppsala, Sweden) and used for eosinophil purifications by negative selection on an AutoMACS Pro separator using the Eosinophil Purification Kit (Miltenyi Biotec, Bergisch Gladbach, Germany). Eosinophil purity was >98% for all samples as determined by counting a minimum of 300 cells on cytospin slides stained with Shandon Diff-Kwik stains (ThermoFisher Scientific, Waltham, MA).
Transwell migration assays were performed in 24-well Transwell plates with 5.0 μm pore inserts (Costar, Corning, NY). 500μL of phenol red free RPMI medium (10%FCS), with or without 100 ng/mL recombinant human CCL11 (eotaxin-1, Peprotech, Cranbury, NJ), 100nM 25-HC (Cayman Biochemicals), 100nM 7α,25di-OHC (Cayman Biochemicals) or the GPR183-specific antagonist NIBR189 (50nM) (Tocris) was added to the lower chamber. 100μL of culture medium containing 3 × 105 cells were then added to the upper chamber. After incubation for 3 h at 37°C and 5% CO2, cells were collected separately from the upper or lower chambers and acquired on an LSRII flow cytometer (BD). The proportion of migrating eosinophils was defined as the number of cells in the lower chamber divided by the sum of the cells in the upper and lower chambers and normalized to the positive control of eotaxin-mediated migration.
+ Open protocol
+ Expand
2

Eosinophil Transwell Migration Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
Granulocyte layers were isolated from peripheral blood after density gradient centrifugation (Ficoll-Paque PLUS, GE Healthcare, Uppsala, Sweden) and used for eosinophil purifications by negative selection on an AutoMACS Pro separator using the Eosinophil Purification Kit (Miltenyi Biotec, Bergisch Gladbach, Germany). Eosinophil purity was >98% for all samples as determined by counting a minimum of 300 cells on cytospin slides stained with Shandon Diff-Kwik stains (ThermoFisher Scientific, Waltham, MA).
Transwell migration assays were performed in 24-well Transwell plates with 5.0 μm pore inserts (Costar, Corning, NY). 500μL of phenol red free RPMI medium (10%FCS), with or without 100 ng/mL recombinant human CCL11 (eotaxin-1, Peprotech, Cranbury, NJ), 100nM 25-HC (Cayman Biochemicals), 100nM 7α,25di-OHC (Cayman Biochemicals) or the GPR183-specific antagonist NIBR189 (50nM) (Tocris) was added to the lower chamber. 100μL of culture medium containing 3 × 105 cells were then added to the upper chamber. After incubation for 3 h at 37°C and 5% CO2, cells were collected separately from the upper or lower chambers and acquired on an LSRII flow cytometer (BD). The proportion of migrating eosinophils was defined as the number of cells in the lower chamber divided by the sum of the cells in the upper and lower chambers and normalized to the positive control of eotaxin-mediated migration.
+ Open protocol
+ Expand
3

Isolation and Purification of Eosinophils

Check if the same lab product or an alternative is used in the 5 most similar protocols
Peripheral blood mononuclear cells (PBMCs) and granulocytes were isolated from whole blood by density gradient separation (Ficoll-Paque PLUS; GE Healthcare, Uppsala, Sweden). After red blood cell lysis using ice-cold ddH2O and 4X PBS, granulocytes were resuspended in eosinophil purification buffer (1X PBS, 1 mM EDTA, 0.5% endotoxin free BSA). Eosinophils were purified from the granulocyte layer by magnetic bead selection on an AutoMACS (Miltenyi Biotech, Cambridge, MA) using the Eosinophil Purification Kit (Miltenyi Biotech). Eosinophil purity was >99% for all HES samples and ≥95% for healthy control samples as determined by counting of a minimum of 300 cells on cytospin slides stained with Diff-Quik (Siemens Healthcare Diagnostics, Malvern, PA).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!